Alzheimer's & Cognition
Feature
Long COVID ‘brain fog’ confounds doctors, but new research offers hope
Brain fog is among the most common symptoms of long COVID, and also one of the most poorly understood.
News
Lean muscle mass protective against Alzheimer’s?
The finding suggesting that lean mass is associated with better cognitive function is “important, as cognitive impairment can become stable rather...
News
Regular napping linked to greater brain volume
“Our results suggest that napping may improve brain health.”
From the Journals
SSRI improves cognition, major depression in early dementia
Improvements in depressive symptoms were irrespective of dementia type.
News
Altered gut bacteria a biomarker of preclinical Alzheimer’s?
It’s not known whether the gut is influencing the brain, or the brain is influencing the gut, “but this association is valuable to know in either...
From the Journals
Patients with post-COVID cognitive symptoms may have gliosis
“This is an important initial step to better understand the neuropsychiatric consequences of COVID even in only a mild and moderate viral illness...
Commentary
Daily multivitamins boost memory in older adults: A randomized trial
Multivitamin supplementation holds promise as a safe, accessible, and affordable approach to protecting cognitive health in older adults.
FDA/CDC
FDA panel unanimously endorses lecanemab for Alzheimer’s
An intravenous infusion targeting amyloid-beta, lecanemab received accelerated FDA approved earlier in 2023 for the treatment of early Alzheimer’s...
From the Journals
Muscle fat: A new risk factor for cognitive decline?
“Increasing adiposity – or fat deposition – in skeletal muscles predicted faster cognitive decline, irrespective of demographics or other disease...
Latest News
Flavanol supplement improves memory in adults with poor diets
The evidence shows that consuming these nutrients might be associated with the hippocampal-dependent memory component of cognitive aging.
FDA/CDC
CMS to cover Alzheimer’s drugs after traditional FDA okay
“If the FDA grants traditional approval, CMS is prepared to ensure anyone with Medicare Part B who meets the criteria is covered.”